/
Login
Analysis Scores
Damodaran ?
24/100
Dalio Risk ?
85/100
Piotroski ?
2/9
Weak
Previous period ROA data missing (C1 delta-ROA); Operating cash flow data missing (C3, C4); Previous year data missing → margin comparison unavailable (C8)
Graham ?
₹221.9
Pahalı
Active Metric?
4/4
Confidence?
75%
Valuation
Potential?
-39.6%
ROIC ?
5.2%
DCF Value ?
111.36
Debt Cycle?
Early Expansion
Data
Data ?
6004
2002-07-01 → 2026-08-31
Risk Analysis (VaR)
Orta
252 days
Annual Volatility ?
%30.5
VaR 95% ?
%3.19
daily max loss
VaR 99% ?
%4.50
daily max loss
CVaR 95% ?
%4.44
expected loss (tail)
Max Drawdown ?
%23.5
27.02.2026 → 31.08.2026
Skewness ?
-0.20
Parametrik%3.19
Historik%3.04
Cornish-Fisher%3.27
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Downtrend
Price (1194.40), TRAMA-99 line's %12.4 below. Downtrend ongoing — technical outlook negative. Pressure may continue until TRAMA is broken above.
Price:: 1194.4000244140625
TRAMA: 1363.5854
Difference: %-12.4
Profitability
Net Profit Margin
%2.4
Net profit margin %2.4 — positive but low. Compared to previous quarter -0.4 point decrease.
ROE – Özkaynak Getirisi (TTM)
%3.7
ROE %3.7 — low return on equity.
EBITDA Margin
%4.7
EBITDA margin %4.7 — low but positive.
Gross Profit Margin
%19.9
Gross profit per revenue %19.9. Evaluate relative to sector.
Valuation
P/E Ratio
100.0x
Sector: 38.5x
F/K 100.0x — sector median's (38.5x) %160 above. Expensive zone.
P/B Ratio
6.20x
Sector: 4.79x
PD/DD 6.20x — sector median's (4.79x) %29 above.
EV/EBITDA
54.6x
Sector: 27.1x
EV/EBITDA 54.6x — sector median's (27.1x) %101 above. EBITDA’ya göre pahalı.
Indebtedness
Current Ratio
1.37x
Current ratio 1.37x — can comfortably cover short-term debts.
Net Debt / EBITDA
1.4x
Net Borç/EBITDA 1.4x — very low debt burden. Company can repay debt quickly.
Debt / Equity
0.16x
Low leverage — majority of assets financed by equity.
Interest Coverage
8.4x
Interest coverage 8.4x — interest obligations comfortably covered.
Growth
Revenue Growth (YoY)
%+2.4
Revenue YoY %2.4 grew — positive but slow growth.
Net Profit Growth (YoY)
%-51.8
Net profit YoY %-51.8 declined (2026/3) — serious profit erosion.
Score Explanations
Lothien Robustness
34/100
Weak robustness (34/100). Valuation metrics and/or debt profile are unfavorable; caution is needed.
Weak
Potential
-39.6%
Minus %39.6 expected value (721.61) vs current price comparison. 4/4 valuation models give 'BUY' signal. Model confidence %75.
Components: PE target: 403.79 | P/B target: 939.24 | EV/EBITDA target: 593.40 | DCF target: 298.60
Damodaran Valuation
24/100
Low Damodaran score (24/100). ROIC (%5.2) below cost of capital. DCF analysis does not support current price.
Very Weak
Dalio Risk Analysis
85/100
Low debt risk (85/100). Interest coverage ratio 8.4x — strong. Borç/EBITDA 1.4x — in healthy range.
Leverage: 90/100 | Debt Service: 84/100 | Quality: 70/100
ROIC – Sermaye Getirisi
%5.2
ROIC (%5.2) cost of capitaln (15.6%) below → destroying value.
WACC: %15.6
DCF Discounted Cash Flow
111.36
DCF (111.36) current price %90.7 below — cash flows do not support current price.
Current price: 1194.40
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
2/9
Weak Piotroski (2/9). Many balance sheet quality criteria not met. Note: Previous period ROA data missing (C1 delta-ROA); Operating cash flow data missing (C3, C4)
Weak
Graham Intrinsic Value
₹221.9
Graham intrinsic value: ₹221.9. Pahalı
Expensive
⚖️ Sector Comparison
P/E Ratio
100.0x
vs 38.5x
Sector mediannın %160 above — expensive
P/B Ratio
6.20x
vs 4.79x
Compared to sector %29 more expensive (by book value)
EV/EBITDA
54.6x
vs 27.1x
Compared to sector %101 higher EV/EBITDA
ROIC vs WACC
%5.2
vs %15.6 WACC
ROIC 10.3 baz puan cost of capitaln altında
Net Profit Margin (TTM)
%2.7
vs %5.2 EBITDA margin
TTM net profit margin %2.7
Charts
Indicators
BB deviation
?
RSI thresholds
?
VOLTAS — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.